Inventor · disambiguated record
Haibo Liu
Also filed as: LIU HAIBO
8 granted patents·7 pending applications·40 citations·filing 2014–2024
83Inventor score
Top patents by PatentIndex Score
15 records- 0192US9321786B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Apr 26, 2016·15 cites·51 claims
- 0289US12162848B2Inhibitors of protein tyrosine phosphatase, compositions, and methods of useBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Dec 10, 2024·1 cites·17 claims
- 0388US9663524B2Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitorsCELGENE CAR LLC·Filed 2014·Granted May 30, 2017·15 cites·27 claims
- 0487US9695132B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2016·Granted Jul 4, 2017·5 cites·63 claims
- 0580US10189794B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2017·Granted Jan 29, 2019·2 cites·56 claims
- 0677US10065966B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2017·Granted Sep 4, 2018·2 cites·27 claims
- 0771US10774052B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2019·Granted Sep 15, 2020·0 cites·31 claims
- 0871US2022332687A1Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2020·Application pending·0 cites
- 0967US2024180886A1Inhibitors of protein tyrosine phosphatase, compositions, and methods of useBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1067US2024207238A1Inhibitors of protein tyrosine phosphatase, compositions, and methods of useBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1166US2024327381A1Compounds and Compositions for Selective Degradation of Engineered ProteinsCELGENE CORP·Filed 2024·Application pending·0 cites
- 1264US2024228476A1Inhibitors of protein tyrosine phosphatase, compositions, and methods of useBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1364US2024238258A1Inhibitors of protein tyrosine phosphatase, compositions, and methods of useBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1462US10618902B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2018·Granted Apr 14, 2020·0 cites·15 claims
- 1555US2023095912A1Composition and Methods for Selective Degradation of Engineered ProteinsCELGENE CORP·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haibo Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →